# Pharmacodynamic and Safety of MBA-P01 in Healthy Male Volunteers

> **NCT03547141** · PHASE1 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MBA-P01
- **DRUG:** BOTOX

## Key facts

- **NCT ID:** NCT03547141
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-16
- **Primary completion:** 2018-08-28
- **Final completion:** 2018-11-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03547141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03547141, "Pharmacodynamic and Safety of MBA-P01 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT03547141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*